← Open Payments lookup

ROBERT BAYLESS: Open Payments

NPI 1306555826 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,538 in 128 payments from 27 companies in 2025. Trend: 2023 $2,113 · 2024 $1,519 · 2025 $2,538

Food & beverage: $2,538
CompanyPaymentsAmount
ABBVIE INC.25$537
Teva Pharmaceuticals USA, Inc.13$233
Novo Nordisk Inc10$186
AstraZeneca Pharmaceuticals LP8$186
Otsuka America Pharmaceutical, Inc.9$178
Amgen Inc.6$111
PFIZER INC.6$104
Boehringer Ingelheim Pharmaceuticals, Inc.5$101
Janssen Pharmaceuticals, Inc3$94
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$91

Products named: REXULTI, AUSTEDO XR, QULIPTA, UBRELVY, AIRSUPRA, JARDIANCE, INVEGA SUSTENNA, CAPLYTA.

Industry payments across WA — which companies pay providers there.